These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3920790)

  • 21. RBC alloimmunization in blood transfusion-dependent beta-thalassemia patients in southern Iran.
    Karimi M; Nikrooz P; Kashef S; Jamalian N; Davatolhagh Z
    Int J Lab Hematol; 2007 Oct; 29(5):321-6. PubMed ID: 17824911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of red cell alloimmunization in multitransfused Egyptian patients with β-thalassemia.
    Hussein E; Ahmed Eldesoukey N; Rihan A; Kamal A
    Arch Pathol Lab Med; 2014 May; 138(5):684-8. PubMed ID: 24786127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Red cell alloantibodies in patients with haemoglobinopathies.
    Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgG subclass distribution of anti-Rh, anti-Kell and anti-Duffy antibodies measured by sensitive haemagglutination assays.
    Michaelsen TE; Kornstad L
    Clin Exp Immunol; 1987 Mar; 67(3):637-45. PubMed ID: 3111763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Red Cell Alloantibodies in Thalassaemia Patients Who Received Ten or More Units of Transfusion.
    Sarkar SK; Shah MS; Begum M; Yunus AM; Aziz MA; Kabir AL; Khan MR; Rahman F; Rahman A
    Mymensingh Med J; 2019 Apr; 28(2):364-369. PubMed ID: 31086152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt.
    Abdelrazik AM; Elshafie SM; El Said MN; Ezzat Ahmed GM; Al-Gamil AK; El Nahhas MG; Sady AA
    Transfusion; 2016 Sep; 56(9):2303-7. PubMed ID: 27351342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incompatible blood transfusions in liver transplant patients with significant red cell alloantibodies.
    Ramsey G; Cornell FW; Hahn LF; Fonzi F; Starzl TE
    Transplant Proc; 1989 Jun; 21(3):3531. PubMed ID: 2500759
    [No Abstract]   [Full Text] [Related]  

  • 28. Review: the Kell, Duffy, and Kidd blood group systems.
    Westhoff CM; Reid ME
    Immunohematology; 2004; 20(1):37-49. PubMed ID: 15373667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review.
    Cheng CK; Lee CK; Lin CK
    Transfusion; 2012 Oct; 52(10):2220-4. PubMed ID: 22339270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hemolytic disease of the newborn caused by maternal allo-immunization against erythrocyte antigens other than A, B and rhesus D].
    Monestier M; Rigal D; Juron-Dupraz F; Meyer F
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):671-80. PubMed ID: 6520354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients.
    Ameen R; Al-Shemmari S; Al-Humood S; Chowdhury RI; Al-Eyaadi O; Al-Bashir A
    Transfusion; 2003 Nov; 43(11):1604-10. PubMed ID: 14617321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody screening & identification in the general patient population at a tertiary care hospital in New Delhi, India.
    Makroo RN; Bhatia A; Hegde V; Chowdhry M; Thakur UK; Rosamma NL
    Indian J Med Res; 2014 Sep; 140(3):401-5. PubMed ID: 25366208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of red blood cell alloimmunization and autoimmunization among 200 multitransfused Egyptian β thalassemia patients.
    El-Beshlawy A; Salama AA; El-Masry MR; El Husseiny NM; Abdelhameed AM
    Sci Rep; 2020 Dec; 10(1):21079. PubMed ID: 33273689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic review.
    Franchini M; Forni GL; Marano G; Cruciani M; Mengoli C; Pinto V; De Franceschi L; Venturelli D; Casale M; Amerini M; Capuzzo M; Grazzini G; Masiello F; Pati I; Veropalumbo E; Vaglio S; Pupella S; Liumbruno GM
    Blood Transfus; 2019 Jan; 17(1):4-15. PubMed ID: 30653458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody screening in repeatedly transfused patients.
    Hassab AH; Sorour AF; Ahmed MI; Salama MA; Aly AK
    Egypt J Immunol; 2008; 15(2):1-14. PubMed ID: 20306683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Red blood cell immunization in haemoglobinopathie: about 84 cases].
    Ben Amor I; Louati N; Khemekhem H; Dhieb A; Rekik H; Mdhaffar M; Gargouri J
    Transfus Clin Biol; 2012 Dec; 19(6):345-52. PubMed ID: 23103424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-transfusion alloimmunization in patients with sickle cell disease.
    Orlina AR; Unger PJ; Koshy M
    Am J Hematol; 1978; 5(2):101-6. PubMed ID: 104621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-G antibodies from the RH system. I. Diagnostic antibodies and their clinical significance].
    Kuśnierz-Alejska G
    Acta Haematol Pol; 1989; 20(2):223-8. PubMed ID: 2517857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alloimmunization to both Rh and Kell system antigens (anti-C and anti-K) in a young thalassemic patient.
    Arora S; Dhawan HK; Sachdev S; Patidar G; Sharma RR; Marwaha N; Trehan A; Marwaha RK
    Indian J Pathol Microbiol; 2010; 53(4):889-90. PubMed ID: 21045471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.